1.Intestinal Paragonimiasis with Colonic Ulcer and Hematochezia in An Elderly Taiwanese Woman.
Chung Te LIU ; Yen Cheng CHEN ; Tso Hsiao CHEN ; Ursula BARGHOUTH ; Chia Kwung FAN
The Korean Journal of Parasitology 2012;50(4):349-352
A 94-year-old female with end-stage renal disease presents with fever, fatigue, and hematochezia. She had previously resided in Hunan Province, China, and Myanmar, and she immigrated to Taiwan 30 years ago. Colonoscopy revealed a colonic ulcer. Biopsy of the colonic ulcer showed ulceration of the colonic mucosa, and many Paragonimus westermani-like eggs were noted. Serum IgG antibody levels showed strong reactivity with P. westermani excretory-secretory antigens by ELISA. Intestinal paragonimiasis was thus diagnosed according to the morphology of the eggs and serologic finding. After treatment with praziquantel, hematochezia resolved. The present case illustrates the extreme manifestations encountered in severe intestinal paragonimiasis.
Aged, 80 and over
;
Animals
;
Anthelmintics/therapeutic use
;
Antibodies, Helminth/blood
;
Antigens, Helminth/immunology
;
Colonic Diseases/complications/drug therapy/*pathology
;
Colonoscopy
;
Enzyme-Linked Immunosorbent Assay
;
Female
;
Gastrointestinal Hemorrhage/complications/drug therapy/*pathology
;
Humans
;
Intestinal Diseases, Parasitic/complications/drug therapy/parasitology/*pathology
;
Kidney Failure, Chronic/complications
;
Paragonimiasis/complications/drug therapy/parasitology/*pathology
;
Paragonimus westermani/*immunology
;
Praziquantel/therapeutic use
;
Taiwan
;
Ulcer/complications/drug therapy/*pathology
2.Colonic Mucosal Necrosis Following Administration of Calcium Polystryrene Sulfonate (Kalimate) in a Uremic Patient.
Mee JOO ; Won Ki BAE ; Nam Hoon KIM ; Seong Rok HAN
Journal of Korean Medical Science 2009;24(6):1207-1211
Colonic necrosis is known as a rare complication following the administration of Kayexalate (sodium polystryrene sulfonate) in sorbitol. We report a rare case of colonic mucosal necrosis following Kalimate (calcium polystryrene sulfonate), an analogue of Kayexalate without sorbitol in a 34-yr-old man. He had a history of hypertension and uremia. During the management of intracranial hemorrhage, hyperkalemia developed. Kalimate was administered orally and as an enema suspended in 20% dextrose water to treat hyperkalemia. Two days after administration of Kalimate enema, he had profuse hematochezia, and a sigmoidoscopy showed diffuse colonic mucosal necrosis in the rectum and sigmoid colon. Microscopic examination of random colonic biopsies by two consecutive sigmoidoscopies revealed angulated crystals with a characteristic crystalline mosaic pattern on the ulcerated mucosa, which were consistent with Kayexalate crystals. Hematochezia subsided with conservative treatment after a discontinuance of Kalimate administration.
Adult
;
Colon/*pathology
;
Gastrointestinal Hemorrhage/etiology
;
Humans
;
Hyperkalemia/drug therapy
;
Intestinal Mucosa/*pathology
;
Male
;
Necrosis/*chemically induced/complications/pathology
;
Polystyrenes/*adverse effects/therapeutic use
;
Uremia/*physiopathology
3.Successful Management of Recurrent Colon Ulcer in Hemodialysis Patient after Conversion to Peritoneal Dialysis.
Ji Young LEE ; In Tae MOON ; Hye Young LEE ; Hang Lak LEE ; Dong Soo HAN
The Korean Journal of Gastroenterology 2015;66(6):350-353
Lower gastrointestinal complications often develop in end stage renal disease patients, and among the more problematic is recurrent colon ulcer. The exact pathogenesis of this condition is not known and there were no specific therapeutic modalities concerning this type of disease entity. We report, with a literature review, a case of recurrent colon ulcer with intermittent hematochezia in an end stage renal disease patient on long term hemodialysis that improved after conversion to peritoneal dialysis.
Aspirin/therapeutic use
;
Colon/pathology
;
Colonic Diseases/complications/*diagnosis/drug therapy
;
Colonoscopy
;
Drug Therapy, Combination
;
Gastrointestinal Hemorrhage
;
Humans
;
Kidney Failure, Chronic/*complications
;
Male
;
Middle Aged
;
Peritoneal Dialysis
;
Recurrence
;
Ticlopidine/therapeutic use
;
Ulcer/complications/*diagnosis/drug therapy
4.Liver Cirrhosis Due to Autoimmune Hepatitis Combined with Systemic Sclerosis.
Byung Chul YOU ; Soung Won JEONG ; Jae Young JANG ; So Mi GOO ; Sang Gyune KIM ; Young Seok KIM ; Chan Hong JEON ; Yoon Mi JEEN
The Korean Journal of Gastroenterology 2012;59(1):48-52
Systemic sclerosis (SSc) is a chronic systemic disease that affects the skin, lungs, heart, gastrointestinal tract, kidneys, and musculoskeletal system. Although up to 90% of patients with scleroderma have been estimated to have gastrointestinal involvement, liver disease has been reported only rarely. A 51-year-old woman was hospitalized due to esophageal variceal bleeding. Her serum was positive for anti-nuclear antibody and anti-centromere antibody. Sclerodactyly was noted on both hands, and she had recently developed Raynaud's syndrome. Punch biopsy of the hand showed hyperkeratosis, regular acanthosis, and increased basal pigmentation in the epidermis, and thick pale collagenous bundles in the dermis. Liver biopsy showed chronic active hepatitis with bridging fibrosis. Consequently, she was diagnosed with liver cirrhosis due to autoimmune hepatitis (AIH) combined with SSc. AIH had subsided after administration of prednisolone at 40 mg per day. She received 5-10 mg/day of prednisolone as an outpatient, and her condition has remained stable. Patients with either AIH or SSc should be monitored for further development of concurrent autoimmune diseases. The early diagnosis of AIH combined with SSc will be helpful in achieving optimal management.
Anti-Inflammatory Agents/therapeutic use
;
Antibodies, Antinuclear/blood
;
Esophageal and Gastric Varices
;
Female
;
Gastrointestinal Hemorrhage
;
Hepatitis, Autoimmune/complications/*diagnosis/drug therapy
;
Humans
;
Liver Cirrhosis/*diagnosis/etiology/pathology
;
Middle Aged
;
Prednisolone/therapeutic use
;
Raynaud Disease/diagnosis
;
Scleroderma, Systemic/complications/*diagnosis
;
Skin/pathology
5.Effects of octreotide on gastric mucosal massive hemorrhage in patients with portal hypertensive gastropathy.
Qiaoliang LE ; Jie ZHANG ; Qizeng XU ; Heyuan GAO
Chinese Journal of Hepatology 2002;10(1):68-68
Adult
;
Aged
;
Female
;
Gastric Mucosa
;
drug effects
;
pathology
;
Gastrointestinal Agents
;
adverse effects
;
therapeutic use
;
Gastrointestinal Hemorrhage
;
drug therapy
;
etiology
;
Humans
;
Hypertension, Portal
;
complications
;
drug therapy
;
Male
;
Middle Aged
;
Octreotide
;
adverse effects
;
therapeutic use
;
Pituitary Hormones, Posterior
;
adverse effects
;
therapeutic use
;
Treatment Outcome
;
Vomiting
;
chemically induced
6.Comparison on Endoscopic Hemoclip and Hemoclip Combination Therapy in Non-variceal Upper Gastrointestinal Bleeding Patients Based on Clinical Practice Data: Is There Difference between Prospective Cohort Study and Randomized Study?.
Su Hyun LEE ; Jin Tae JUNG ; Dong Wook LEE ; Chang Yoon HA ; Kyung Sik PARK ; Si Hyung LEE ; Chang Heon YANG ; Youn Sun PARK ; Seong Woo JEON
The Korean Journal of Gastroenterology 2015;66(2):85-91
BACKGROUND/AIMS: Endoscopic hemoclip application is an effective and safe method of endoscopic hemostasis. We conducted a multicenter retrospective study on hemoclip and hemoclip combination therapy based on prospective cohort database in terms of hemostatic efficacy not in clinical trial but in real clinical practice. METHODS: Data on endoscopic hemostasis for non-variceal upper gastrointestinal bleeding (NVUGIB) were prospectively collected from February 2011 to December 2013. Among 1,584 patients with NVUGIB, 186 patients treated with hemoclip were enrolled in this study. Subjects were divided into three groups: Group 1 (n=62), hemoclipping only; group 2 (n=88), hemoclipping plus epinephrine injection; and group 3 (n=36), hemocliping and epinephrine injection plus other endoscopic hemostatic modalities. Primary outcomes included rebleeding, other therapeutic management, hospitalization period, fasting period and mortality. Secondary outcomes were bleeding associated mortality and overall mortality. RESULTS: Active bleeding and peptic ulcer bleeding were more common in group 3 than in group 1 and in group 2 (p<0.001). However, primary outcomes (rebleeding, other management, morbidity, hospitalization period, fasting period and mortality) and secondary outcomes (bleeding associated mortality and total mortality) were not different among groups. CONCLUSIONS: Combination therapy of epinephrine injection and other modalities with hemoclips did not show advantage over hemoclipping alone in this prospective cohort study. However, there is a tendency to perform combination therapy in active bleeding which resulted in equivalent hemostatic success rate, and this reflects the role of combination therapy in clinical practice.
Adult
;
Aged
;
Angiography
;
Cohort Studies
;
Combined Modality Therapy
;
Databases, Factual
;
Epinephrine/therapeutic use
;
Female
;
Gastrointestinal Hemorrhage/etiology/*therapy
;
*Hemostasis, Endoscopic
;
Humans
;
Male
;
Middle Aged
;
Prospective Studies
;
Proton Pump Inhibitors/therapeutic use
;
Retrospective Studies
;
Stomach Ulcer/complications/drug therapy/pathology
;
Surgical Instruments
;
Treatment Outcome